Cargando…
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
Triple negative breast cancer is distinguished by its high malignancy, aggressive invasion, rapid progression, easy recurrence, and distant metastases. Additionally, it has a poor prognosis, a high mortality, and is unresponsive to conventional endocrine and targeted therapy, making it a challenging...
Autores principales: | Fu, Yeqin, Yang, Qiuhui, Yang, Hongjian, Zhang, Xiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134903/ https://www.ncbi.nlm.nih.gov/pubmed/37122564 http://dx.doi.org/10.3389/fmolb.2023.1162463 |
Ejemplares similares
-
Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases
por: Rashid, Humaira, et al.
Publicado: (2020) -
The role of microRNAs in ferroptosis
por: Guo, Liqing, et al.
Publicado: (2022) -
NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021) -
MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression
por: Tang, Lin, et al.
Publicado: (2022) -
MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2021)